Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

pRotective vEntilation with veno-venouS lung assisT in respiratory failure: A protocol for a multicentre randomised controlled trial of extracorporeal carbon dioxide removal in patients with acute hypoxaemic respiratory failure.

McNamee JJ, Gillies MA, Barrett NA, Agus AM, Beale R, Bentley A, Bodenham A, Brett SJ, Brodie D, Finney SJ, Gordon AJ, Griffiths M, Harrison D, Jackson C, McDowell C, McNally C, Perkins GD, Tunnicliffe W, Vuylsteke A, Walsh TS, Wise MP, Young D, McAuley DF.

J Intensive Care Soc. 2017 May;18(2):159-169. doi: 10.1177/1751143716681035. Epub 2016 Dec 19.

2.

The Right Ventricle in ARDS.

Zochios V, Parhar K, Tunnicliffe W, Roscoe A, Gao F.

Chest. 2017 Jul;152(1):181-193. doi: 10.1016/j.chest.2017.02.019. Epub 2017 Mar 4. Review.

PMID:
28267435
3.

A randomised controlled trial and cost-effectiveness analysis of high-frequency oscillatory ventilation against conventional artificial ventilation for adults with acute respiratory distress syndrome. The OSCAR (OSCillation in ARDS) study.

Lall R, Hamilton P, Young D, Hulme C, Hall P, Shah S, MacKenzie I, Tunnicliffe W, Rowan K, Cuthbertson B, McCabe C, Lamb S; OSCAR collaborators.

Health Technol Assess. 2015 Mar;19(23):1-177, vii. doi: 10.3310/hta19230.

4.

High-frequency oscillation for acute respiratory distress syndrome.

Young D, Lamb SE, Shah S, MacKenzie I, Tunnicliffe W, Lall R, Rowan K, Cuthbertson BH; OSCAR Study Group.

N Engl J Med. 2013 Feb 28;368(9):806-13. doi: 10.1056/NEJMoa1215716. Epub 2013 Jan 22.

5.

Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial.

Gao Smith F, Perkins GD, Gates S, Young D, McAuley DF, Tunnicliffe W, Khan Z, Lamb SE; BALTI-2 study investigators.

Lancet. 2012 Jan 21;379(9812):229-35. doi: 10.1016/S0140-6736(11)61623-1. Epub 2011 Dec 11.

6.

Type XVIII collagen degradation products in acute lung injury.

Perkins GD, Nathani N, Richter AG, Park D, Shyamsundar M, Heljasvaara R, Pihlajaniemi T, Manji M, Tunnicliffe W, McAuley D, Gao F, Thickett DR.

Crit Care. 2009;13(2):R52. doi: 10.1186/cc7779. Epub 2009 Apr 9.

7.

Effect of social factors on winter hospital admission for respiratory disease: a case-control study of older people in the UK.

Jordan RE, Hawker JI, Ayres JG, Adab P, Tunnicliffe W, Olowokure B, Kai J, McManus RJ, Salter R, Cheng KK.

Br J Gen Pract. 2008 Jun;58(551):400-2. doi: 10.3399/bjgp08X302682.

8.

Kerbs von Lungren 6 antigen is a marker of alveolar inflammation but not of infection in patients with acute respiratory distress syndrome.

Nathani N, Perkins GD, Tunnicliffe W, Murphy N, Manji M, Thickett DR.

Crit Care. 2008;12(1):R12. doi: 10.1186/cc6785. Epub 2008 Jan 23.

9.

A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004.

Jordan RE, Hawker JI, Ayres JG, Tunnicliffe W, Adab P, Olowokure B, Kai J, McManus RJ, Salter R, Cheng KK.

Vaccine. 2007 Nov 14;25(46):7909-13. Epub 2007 Sep 21.

PMID:
17935837
11.

The effect of exposure to sulphuric acid on the early asthmatic response to inhaled grass pollen allergen.

Tunnicliffe WS, Evans DE, Mark D, Harrison RM, Ayres JG.

Eur Respir J. 2001 Oct;18(4):640-6.

12.

The effect of sulphur dioxide exposure on indices of heart rate variability in normal and asthmatic adults.

Tunnicliffe WS, Hilton MF, Harrison RM, Ayres JG.

Eur Respir J. 2001 Apr;17(4):604-8.

13.
14.

Pulmonary function and respiratory symptoms in a population of airport workers.

Tunnicliffe WS, O'Hickey SP, Fletcher TJ, Miles JF, Burge PS, Ayres JG.

Occup Environ Med. 1999 Feb;56(2):118-23.

15.

Dietary antioxidants and magnesium in type 1 brittle asthma: a case control study.

Baker JC, Tunnicliffe WS, Duncanson RC, Ayres JG.

Thorax. 1999 Feb;54(2):115-8.

16.

Sensitivity and exposure to indoor allergens in adults with differing asthma severity.

Tunnicliffe WS, Fletcher TJ, Hammond K, Roberts K, Custovic A, Simpson A, Woodcock A, Ayres JG.

Eur Respir J. 1999 Mar;13(3):654-9.

17.
18.

Chlamydia pneumoniae and asthma.

Cook PJ, Davies P, Tunnicliffe W, Ayres JG, Honeybourne D, Wise R.

Thorax. 1998 Apr;53(4):254-9.

19.

Post-infection fatigue syndrome following Q fever.

Ayres JG, Flint N, Smith EG, Tunnicliffe WS, Fletcher TJ, Hammond K, Ward D, Marmion BP.

QJM. 1998 Feb;91(2):105-23.

PMID:
9578893
20.

Psychological morbidity and coping skills in patients with brittle and non-brittle asthma: a case-control study.

Miles JF, Garden GM, Tunnicliffe WS, Cayton RM, Ayres JG.

Clin Exp Allergy. 1997 Oct;27(10):1151-9.

PMID:
9383255
21.

Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease.

Fletcher TJ, Tunnicliffe WS, Hammond K, Roberts K, Ayres JG.

BMJ. 1997 Jun 7;314(7095):1663-5. No abstract available.

22.
23.

Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients.

Tunnicliffe WS, Burge PS, Ayres JG.

Lancet. 1994 Dec 24-31;344(8939-8940):1733-6.

PMID:
7997002
24.

Rate of asthmatic attacks.

Ayres J, Tunnicliffe W, Miles J, Fleming D, Ross A.

BMJ. 1993 Apr 17;306(6884):1069. No abstract available.

25.

Impedance of the human head as observed during electro-shock treatment.

UMLAUF CW, GUNTER RC Jr, TUNNICLIFFE WW.

Confin Neurol. 1951;11(3):129-38. No abstract available.

PMID:
14831358

Supplemental Content

Loading ...
Support Center